We use first- and third-party cookies to provide our services and collect statistical data. By continuing to browse you accept these cookies. More information Accept
Brands / NEURAXPHARM / France
Neuraxpharm France

Neuraxpharm France
IS A LEADING FRENCH CNS COMPANY

in branded and original anxiety products
NEURAXPHARM FRANCE

NEURAXPHARM FRANCE

is a key player in the CNS area by providing a wide range of proven, differentiated and affordable treatment options to healthcare professionals and patients
The company focuses on the sale and marketing of branded pharmaceutical products in France, mainly used to treat anxiety disorders, including leading brands such as SERESTA® and TEMESTA®
BRANDNEURAX2_METAS_BLOCKMAPS_ALT
Headquartered in Paris (France)
NEURAXPHARM FRANCE IS A SPECIALTY PHARMACEUTICAL COMPANY
focused on the commercialisation of CNS pharmaceuticals in France
BRANDNEURAX2_METAS_FOCUS_ALT

FOCUS

Pipeline with a strong focus on CNS pathologies
ANXIETY
BRANDNEURAX2_METAS_PORTFOLIO_ALT

PORTFOLIO

  • Distribution focus on branded CNS pharmaceuticals
  • Specialist in anxiety pharmaceuticals
  • 2 key brands: SERESTA® (Oxazepam) and TEMESTA® (Lorazepam)
BRANDNEURAX2_METAS_PORTFOLIO_ALT
82%
CNS PRODUCTS
18%
OTHER
BRANDNEURAX2_METAS_SALES_ALT

SALES DRIVER

  • BRANDNEURAX2_METAS_SALES_ALT_LIST01 Established and original brands with proven efficacy
  • BRANDNEURAX2_METAS_SALES_ALT_LIST02 Currently among the top three companies in the CNS-anxiety market in France
  • BRANDNEURAX2_METAS_SALES_ALT_LIST03 Structure prepared to increase portfolio with new CNS products coming from the Group
  • BRANDNEURAX2_METAS_SALES_ALT_LIST04 Robust supply chain to ensure product availability and export business to the African French speaking countries
BRANDNEURAX2_METAS_HOLDS_ALT

NEURAXPHARM
FRANCE

HOLDS A 20%

market share in the French anxiolytics market